Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

81.71
Delayed Data
As of Nov 22
 +0.43 / +0.53%
Today’s Change
58.66
Today|||52-Week Range
88.98
+38.05%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Biotech ETFs: What Lies Ahead?
Nov 13 / Zacks.com - Paid Partner Content
 

Performance

1 month-4.52% 3 years+12.59%
3 months+5.93% 5 years+23.56%
1 year+26.83% Since inception+14.92%
Data through 11/23/2017

Quote Details

Previous close$81.28
Open day’s range81.04 – 81.88
Net asset value (NAV)81.75 (11/22/2017)
Daily volume2,376,588
Average volume (3 months)3,633,307
Data as of 8:00pm ET, 11/22/2017

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+23.56%+16.79%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.881.11
Net assets$4.3B$3.1B
Average market cap$4.5B$27.3B
Average P/E--22.4
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ALNY Alnylam Pharmaceuticals Inc3.18%
EXAS Exact Sciences Corp2.49%
PBYI Puma Biotechnology Inc2.35%
SGEN Seattle Genetics Inc2.23%
SRPT Sarepta Therapeutics Inc2.21%
AVXS AveXis Inc2.17%
CLVS Clovis Oncology Inc2.16%
BLUE bluebird bio Inc2.15%
NBIX Neurocrine Biosciences Inc2.07%
JUNO Juno Therapeutics Inc2.07%